Apremilast FDA approval date

The FDA approved Apremilast on 21 Mar 2014.

FDA approval date
21 Mar 2014

Drug identity checked against registry records

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2014-03-21DayApremilastFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205437", "applicant_as_listed_by_fda": "AMGEN INC", "brand_names": ["OTEZLA"], "active_ingredients": ["APREMILAST"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20140321", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026